NeoDynamics

NeoDynamics sets up NeoDynamics USA Inc.

Tue, Mar 15, 2022 08:55 CET

As part of the preparations for launching its innovative NeoNavia biopsy system in the US market, the medical technology company NeoDynamics has started a subsidiary in the USA, NeoDynamics USA Inc. The subsidiary makes it easier for NeoDynamics to recruit and hire employees, and enter into various types of agreements which will directly support the launch. Currently, NeoDynamics has Anna Forsberg operating locally in the US to lead the activities required to register the product with the US Food and Drug Administration. Business Development Manager Magnus Precht explains the investment

NeoDynamics has filed for registration of NeoNavia® in the US

Tue, Mar 01, 2022 07:46 CET

The MedTech company NeoDynamics has filed a registration application for its innovative pulse biopsy system NeoNavia® with the US Food and Drug Administration, FDA. The product already has CE approval in Europe and is in clinical use. “By filing for registration of NeoNavia in the US, NeoDynamics reaches an important milestone. The US is a huge potential market for NeoNavia and a US registration is also an important seal of quality for future collaborations”, says CEO Anna Eriksrud. “We expect that it will take a number of months to get the registration application approved.” The

Share

NeoDynamics sets up NeoDynamics USA Inc.

NeoDynamics has filed for registration of NeoNavia® in the US